Graft and Patient Survival

[1]  X. Jouven,et al.  Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. , 2015, Journal of the American Society of Nephrology : JASN.

[2]  A. Israni,et al.  OPTN/SRTR 2013 Annual Data Report: Kidney , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  R. Varadhan,et al.  Frailty and Mortality in Kidney Transplant Recipients , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  C. Gross,et al.  Quality of Life in Elderly Kidney Transplant Recipients , 2014, Journal of the American Geriatrics Society.

[5]  Christopher T. Chan,et al.  Survival and hospitalization for intensive home hemodialysis compared with kidney transplantation. , 2014, Journal of the American Society of Nephrology : JASN.

[6]  J M Smith,et al.  OPTN/SRTR 2012 Annual Data Report: Kidney , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  X. Jouven,et al.  Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.

[8]  F. Citterio,et al.  The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. , 2013, Transplantation proceedings.

[9]  Lu Tian,et al.  A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data , 2013, Statistics in medicine.

[10]  G. Knoll.  Kidney transplantation in the older adult. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  A. Gaber,et al.  Screening for BK Viremia Reduces But Does Not Eliminate the Risk of BK Nephropathy: A Single-Center Retrospective Analysis , 2013, Transplantation.

[12]  Rachel J. Johnson,et al.  Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study , 2013, The Lancet.

[13]  G. Russ,et al.  Outcomes of Kidney Transplantation From Older Living Donors , 2013, Transplantation.

[14]  A. Israni,et al.  OPTN/SRTR 2011 Annual Data Report: Kidney , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  G. Gupta,et al.  Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[16]  Harshal R. Patil,et al.  Effect of renal transplantation for chronic renal disease on left ventricular mass. , 2012, The American journal of cardiology.

[17]  M. Makary,et al.  Frailty and delayed graft function in kidney transplant recipients. , 2012, Archives of surgery.

[18]  Rachel J. Johnson,et al.  A Simplified Donor Risk Index for Predicting Outcome After Deceased Donor Kidney Transplantation , 2012, Transplantation.

[19]  J. Ringers,et al.  Kidneys from donors after cardiac death provide survival benefit. , 2010, Journal of the American Society of Nephrology : JASN.

[20]  A. Hartmann,et al.  Experience From an Active Preemptive Kidney Transplantation Program—809 Cases Revisited , 2009, Transplantation.

[21]  Douglas E Schaubel,et al.  A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk Index , 2009, Transplantation.

[22]  J. Schold,et al.  Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[23]  L. Resende,et al.  Influence of dialysis duration and modality on kidney transplant outcomes. , 2009, Transplantation proceedings.

[24]  G S Jhangri,et al.  Peritubular Capillaritis in Renal Allografts: Prevalence, Scoring System, Reproducibility and Clinicopathological Correlates , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  D. Nochy,et al.  Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. , 2008, Contributions to nephrology.

[26]  D. Nochy,et al.  Clinical Relevance of Preformed HLA Donor‐Specific Antibodies in Kidney Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  T. Larson,et al.  Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  D. Geetha,et al.  Ureteral stents: a novel risk factor for polyomavirus nephropathy. , 2007, Transplantation.

[29]  E. Lerut,et al.  Subclinical Peritubular Capillaritis at 3 Months Is Associated With Chronic Rejection at 1 Year , 2007, Transplantation.

[30]  M. Stegall,et al.  Protocol Biopsies in Renal Transplantation: Insights into Patient Management and Pathogenesis , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  J. Fishman,et al.  Disparities in Solid Organ Transplantation for Ethnic Minorities: Facts and Solutions , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[32]  A. Ojo.  Cardiovascular Complications After Renal Transplantation and Their Prevention , 2006, Transplantation.

[33]  M. Stegall,et al.  Histologic Findings One Year After Positive Crossmatch or ABO Blood Group Incompatible Living Donor Kidney Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  S. Fuggle,et al.  Major effects of delayed graft function and cold ischaemia time on renal allograft survival. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  J. Schold,et al.  Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[36]  R. Wolfe,et al.  Deceased-donor characteristics and the survival benefit of kidney transplantation. , 2005, JAMA.

[37]  D. Rush.  Protocol transplant biopsies: an underutilized tool in kidney transplantation. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[38]  M. Tonelli,et al.  The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. , 2005, Kidney international.

[39]  M. Unruh,et al.  Comorbid conditions in kidney transplantation: association with graft and patient survival. , 2005, Journal of the American Society of Nephrology : JASN.

[40]  T. Larson,et al.  Predicting Subsequent Decline in Kidney Allograft Function from Early Surveillance Biopsies , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  M. Ohno,et al.  Peritubular capillaritis in early renal allograft is associated with the development of chronic rejection and chronic allograft nephropathy , 2005, Clinical transplantation.

[42]  G. Oniscu,et al.  Impact of cadaveric renal transplantation on survival in patients listed for transplantation. , 2005, Journal of the American Society of Nephrology : JASN.

[43]  Chul-woo Yang,et al.  Clinical Significance of an Early Protocol Biopsy in Living‐Donor Renal Transplantation: Ten‐Year Experience at a Single Center , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[44]  M. Suthanthiran,et al.  Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations , 2005, Transplantation.

[45]  A. Kirk,et al.  Functionally Significant Renal Allograft Rejection Is Defined by Transcriptional Criteria , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[46]  R. Hasz,et al.  Expanded-Criteria Donor Kidneys: A Single-Center Clinical and Short-Term Financial Analysis—Cause for Concern in Retransplantation , 2004, Transplantation.

[47]  K. Johansen,et al.  Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. , 2004, Journal of the American Society of Nephrology : JASN.

[48]  J. Morales,et al.  Early Cyclosporine A Withdrawal in Kidney-Transplant Recipients Receiving Sirolimus Prevents Progression of Chronic Pathologic Allograft Lesions , 2004, Transplantation.

[49]  S. Head,et al.  De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two Years , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[50]  F. Moreso,et al.  Baseline Immunosuppression is Associated with Histological Findings in Early Protocol Biopsies , 2004, Transplantation.

[51]  A. Cueto-Manzano,et al.  Markers of Inflammation Before and After Renal Transplantation , 2005, Transplantation.

[52]  J. Chapman,et al.  Natural History, Risk Factors, and Impact of Subclinical Rejection in Kidney Transplantation , 2004, Transplantation.

[53]  A. Kazory,et al.  Predicting coronary heart disease in renal transplant recipients: a prospective study. , 2004, Kidney international.

[54]  L. Mateu,et al.  Acute rejection and late renal transplant failure: Risk factors and prognosis , 2004 .

[55]  H. Schlitt,et al.  Cardiovascular morbidity and mortality in patients with diabetes mellitus type I after kidney transplantation: a case-control study. , 2004, Clinical nephrology.

[56]  J. Schold,et al.  Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[57]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[58]  G. Molema,et al.  Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. , 2003, Kidney international.

[59]  P. Nickerson,et al.  Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. , 2003, Journal of the American Society of Nephrology : JASN.

[60]  H. Asanuma,et al.  The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.

[61]  T. Paavonen,et al.  Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies. , 2003, Journal of the American Society of Nephrology : JASN.

[62]  E. Briganti,et al.  Risk of renal allograft loss from recurrent glomerulonephritis. , 2002, The New England journal of medicine.

[63]  R. Howard,et al.  The changing causes of graft loss and death after kidney transplantation , 2002, Transplantation.

[64]  B. Kasiske,et al.  Preemptive kidney transplantation: the advantage and the advantaged. , 2002, Journal of the American Society of Nephrology : JASN.

[65]  T. Theruvath,et al.  Strategies to improve long-term outcomes after renal transplantation. , 2002, The New England journal of medicine.

[66]  F. Moreso,et al.  Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. , 2002, Kidney international.

[67]  G. Opelz,et al.  Cyclosporine and long-term kidney graft survival. , 2001, Transplantation.

[68]  F. Port,et al.  Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. , 2001, Journal of the American Society of Nephrology : JASN.

[69]  J. Chapman,et al.  EFFECT OF HISTOLOGICAL DAMAGE ON LONG-TERM KIDNEY TRANSPLANT OUTCOME , 2001, Transplantation.

[70]  A. Nagler,et al.  INCREASED IMPACT OF ACUTE REJECTION ON CHRONIC ALLOGRAFT FAILURE IN RECENT ERA , 2000, Transplantation.

[71]  A. Van Daele,et al.  Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts. , 2000, Transplantation.

[72]  E. Condom,et al.  Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. , 2000, Transplantation.

[73]  D. Churchill,et al.  Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. , 2000, Journal of the American Society of Nephrology : JASN.

[74]  S. Hariharan,et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.

[75]  R. Wolfe,et al.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. , 1999, The New England journal of medicine.

[76]  Xin Qun Wang,et al.  Racial disparities in renal transplant outcomes. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[77]  R. Ouseph,et al.  Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). , 1999, Transplantation.

[78]  J. Chapman,et al.  Predictors of renal transplant histology at three months. , 1999, Transplantation.

[79]  F. Vincenti,et al.  Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine , 1998 .

[80]  P. Nickerson,et al.  Beneficial effects of treatment of early subclinical rejection: a randomized study. , 1998, Journal of the American Society of Nephrology : JASN.

[81]  D. Lorenz,et al.  Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. , 1998, Journal of the American Society of Nephrology : JASN.

[82]  E. Thervet,et al.  Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. , 1998, Transplantation.

[83]  P. Nickerson,et al.  Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. , 1998, Journal of the American Society of Nephrology : JASN.

[84]  H. Redmond,et al.  Thermotolerance attenuates ischemia-reperfusion induced renal injury and increased expression of ICAM-1. , 1996, Transplantation.

[85]  R. Wolfe,et al.  Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. , 1994, American Journal of Kidney Diseases.

[86]  T. Fujinami,et al.  Studies of cyclosporine-associated arteriolopathy in renal transplantation: does the long-term outcome of renal allografts depend on chronic cyclosporine nephrotoxicity? , 1994, Transplantation proceedings.

[87]  R. Wolfe,et al.  Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. , 1993, JAMA.

[88]  H. Isoniemi,et al.  LONG‐TERM CONSEQUENCES OF DIFFERENT IMMUNOSUPPRESSIVE REGIMENS FOR RENAL ALLOGRAFTS , 1993, Transplantation.

[89]  S. Flechner,et al.  Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[90]  M. First,et al.  Transplant glomerulopathy: evolution of morphologically distinct changes. , 1985, Kidney international.

[91]  A. Figueiredo,et al.  Delayed renal graft function: risk factors and impact on the outcome of transplantation. , 2011 .

[92]  A. Schwarz,et al.  Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. , 2005, Kidney international.

[93]  John F. Hurdle,et al.  Duration of end-stage renal disease and kidney transplant outcome. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[94]  F. Locatelli,et al.  Renal replacement therapy in patients with diabetes and end-stage renal disease. , 2004, Journal of the American Society of Nephrology : JASN.

[95]  E. Condom,et al.  Early protocol renal allograft biopsies and graft outcome. , 1997, Kidney international.

[96]  M. Suthanthiran,et al.  Medical progress : renal transplantation , 1994 .

[97]  H. Isoniemi,et al.  Histopathological findings in well-functioning, long-term renal allografts. , 1992, Kidney international.